Delivery Order SPE2DB20D2001-SPE2DB22FM44L
- Not listed
- This federal contract award, with ID SPE2DB20D2001|SPE2DB23FM34M, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,084.96 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray in 30 mL containers. The contract has an ultimate completion date of January 4, 2023 and was awarded on January 3, 2023. There was no set-aside designation for this award. Amerisourcebergen Drug Corp, as a major...
- This federal contract award, with the ID SPE2DX15D1053|SPE2DX24F6PTE, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,149.81 firm fixed price delivery order is for the supply of azelastine 0.1% (137 mcg) spray in 30 ml containers. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary...
- This contract award (SPE2DB20D2104|SPE2DB22FS22R) is for the delivery of Azelastine 0.1% (137 MCG) nasal spray, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,005.24 and a performance period ending on March 29, 2022. The contract was not set aside for any specific business...
- The Defense Logistics Agency awarded a $1,160.88 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Azelastine 0.1% (137 mcg) spray in a 30 mL container. The contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. Performance will be completed by December 12, 2025, with fulfillment occurring...
- The Defense Logistics Agency awarded a $1,645.08 delivery order to AmerisourceBergen Drug Corp for Azelastine 0.1% (137 mcg) spray in a 30-milliliter formulation on December 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of December 19, 2025, represents a competitively awarded contract with no set-aside designation. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order, this...
- The Defense Logistics Agency awarded a $261 delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As part of DLA's medical supply chain support to the Department of Defense, this firm fixed price order calls for delivery of 137 microgram sprays in 30 milliliter bottles from Amerisourcebergen's facility in Conshohocken, Pennsylvania. The parent company, Amerisourcebergen Corporation, will perform through its corporate office division. No subcontractors...
- The Defense Logistics Agency awarded a $87 firm fixed price delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply 4561911878 units of the 0.1% 137 mcg spray to the DLA under a one-day period of performance ending August 24, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the contract from its facilities in Conshohocken, Pennsylvania. The delivery order was issued...
- The Defense Logistics Agency awarded a $174 firm fixed price delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply 4561315731 units of the 0.1% 137 mcg/spray product to the DLA under a one-day period of performance in Conshohocken, Pennsylvania. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle, though details of the base contract were not provided....
- The Defense Logistics Agency awarded a $1,045 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Azelastine hydrochloride nasal spray. Under this contract, Amerisourcebergen will provide 4562138279 units of the 0.1% 137 mcg/spray nasal spray to fulfill DLA requirements. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 12 through September 13, 2023. As a leading pharmaceutical distributor,...
- The Defense Logistics Agency awarded a $261 delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply approximately 137 micrograms of the nasal spray packaged in 30ml bottles to fulfill DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period from August 29 to 30, 2023. The firm fixed price contract was awarded utilizing...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB22FM44LDelivery Order
This federal contract award, identified as SPE2DB20D2001|SPE2DB22FM44L, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,660.44 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) nasal spray, a medication used for the treatment of nasal symptoms associated with allergies. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under the "Amerisourcebergen" name. This contract award is not designated as a set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that larger IDC contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 3/1/22 |